CLINICAL_TRIALS
trial_result
· 2008-04-03
Clinical Trial Update: Once Daily Given Alfuzosin in the Treatment of BPH [Phase 4]
Summary
This clinical trial update reports the completion of a Phase 4 study evaluating once-daily alfuzosin for benign prostatic hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Benign Prostatic Hyperplasia | Phase 4 | Status: COMPLETED